Va. to get more than $2m from drug settlement

Published



RICHMOND, Va. (AP) — GlaxoSmithKline will pay Virginia more than $2 million as part of a settlement between the drug maker and 45 states.

Attorney General Mark R. Herring says the $105 million settlement resolves allegations that GlaxoSmithKline improperly marketed the asthma drug Advair and two antidepressant drugs.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.